
Interventional Pulmonary Outcomes Group
@ipulmog
International society focused on advancing the field of interventional pulmonology with impactful clinical trials.
ID: 1681363369624731657
18-07-2023 18:00:48
72 Tweet
232 Followers
52 Following

Hope to see you TOMORROW at 11am EST for our ATS TO Assembly American Thoracic Society (ATS) webinar on #LungCancerScreening Incidental Findings! site.thoracic.org/events/lung-ca…




Be sure to check out our annual American Thoracic Society (ATS) ATS_Assemblies Thoracic Oncology Assembly newsletter, in anticipation of #ATS2025 in a few weeks! 👇🏼👇🏼👇🏼 craftprd1.blob.core.windows.net/documents/memb…



The ATS TO Assembly members meeting is this Sunday at 5pm. See you all soon! American Thoracic Society (ATS) ATS_Assemblies ATS Early Career Interventional Pulmonary Outcomes Group AABIP


Thank you to the ATS TO Assembly for planning such a marvelous meeting! We look forward to seeing what’s next in #ThoracicOncology and #InterventionalPulmonology research!


Congratulations to IPOG members Anil Vachani and Yeon Wook Kim on their ATS TO Assembly career achievement awards! Keep up the good work gentlemen!



Grateful to ATS Blue Journal for publishing our position paper on finding equity in delivery of interventional pulmonary care. Congrats to Roger Kim, MD, MSCE, DAABIP, ATSF for seeing it through to the finish line! Christine Argento M. Patricia Rivera. atsjournals.org/doi/10.1164/rc… Interventional Pulmonary Outcomes Group ATS TO Assembly CHEST


Congrats Ankush Ratwani, MD, MSc and Samira Shojaee: interesting study comparing the utility of CXR and US in assessing evacuation of pleural fluid after throacentesis. pubmed.ncbi.nlm.nih.gov/40439529/


A great team effort on this publication! Appreciate the recognition from ATS Blue Journal and grateful for the team of dedicated interventional pulmonologists we work with to advance the field.


@Alliance_org, in partnership with Interventional Pulmonary Outcomes Group, AABIP and SIO, is developing a clinical trial testing whether adding intratumorally injected LSAM-PTX to standard chemo-immunotherapy in stage II–III NSCLC can improve outcomes. Help shape the trial: bit.ly/3Fu1TTA


Worth a read: Dr Ken Chan (CUHK Medicine) & Estee Lau (Edith Cowan University (ECU)) reviewed current controversies of Pleural Infection Alejandro Irish Thoracic Society ASM The Royal Australasian College of Physicians TSANZ Wales Pleural Group UK Pleural Society AABIP WABIP The Chinese University of Hong Kong - CUHK Interventional Pulmonary Outcomes Group CHEST
